Celyad Oncology SA (EBR:CYAD)
Belgium · Delayed Price · Currency is EUR 0.2610
0.00 (0.00%)
Aug 31, 2026, 1:46 PM CET
Celyad Oncology Market Cap
Celyad Oncology has a market cap or net worth of €11.68 million as of August 31, 2026. Its market cap has decreased by -18.18% in one year.
Market Cap
11.68M
Enterprise Value
9.97M
Revenue
21.00K
Ranking
n/a
PE Ratio
14.50
Stock Price
€0.26
ChartMarket Cap Chart
Since July 4, 2013, Celyad Oncology's market cap has decreased from 101.99M to 11.68M, a decrease of -88.55%. That is a compound annual growth rate of -15.17%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 31, 2026 | 11.68M | 53.53% |
| Dec 31, 2025 | 7.61M | -74.20% |
| Dec 31, 2024 | 29.50M | 82.56% |
| Dec 29, 2023 | 16.16M | 41.33% |
| Dec 30, 2022 | 11.43M | -85.60% |
| Dec 31, 2021 | 79.42M | -13.96% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| argenx SE | 55.98B |
| UCB SA | 41.28B |
| Financière de Tubize | 8.30B |
| Onward Medical | 171.74M |
| Hyloris Pharmaceuticals | 123.76M |
| European Medical Solutions | 14.81M |
| BioSenic | 1.31M |
| Oxurion NV | 230.60K |